stockrowAvantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Operating cash flow
Avantor, Inc.'s operating cash flow for fiscal 2025 was $623.8M, down 25.8% from $840.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $584.7M. Over the past ten years it has ranged from −$167.5M (fiscal 2017) to $953.6M (fiscal 2021); the current reading is higher than 50% of that period. Avantor, Inc. ranks 10th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $623.8M | (25.81%) |
| FY2024 | $840.8M | (3.36%) |
| FY2023 | $870.0M | 3.13% |
| FY2022 | $843.6M | (11.54%) |
| FY2021 | $953.6M | 2.56% |
| FY2020 | $929.8M | 162.66% |
| FY2019 | $354.0M | 76.56% |
| FY2018 | $200.5M | — |
| FY2017 | −$167.5M | — |
| FY2016 | $72.9M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $195.1M | 9.48% |
| Jun 2026 | $178.2M | 203.58% |
| Mar 2026 | $58.7M | (61.56%) |
| Dec 2025 | $152.7M | (26.37%) |
| 31 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BAX Baxter International Inc. compare | $1.6B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $749.9M |
| AVTR Avantor, Inc. | $584.7M |
| ATR AptarGroup, Inc. compare | $573.5M |
| BLCO Bausch + Lomb Corporation compare | $554.0M |
| SOLV Solventum Corporation compare | $310.0M |
| RGEN Repligen Corporation compare | $129.9M |
| TFX Teleflex Incorporated compare | $129.3M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on AVTR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement